Company overview
Yuxi Walvax Biotechnology Co., Ltd.
USCC
91530400770492152K
Id2
530400005000529
English Name
Yuxi Walvax Biotechnology Co., Ltd.
Former names
-
Chinese Name
玉溪沃森生物技术有限公司
Entity type
Other Limited Liability Company
Authorized capital
¥138,737
349171413@qq.com
Phone
+868772076210
Representative
黄镇 (Huang Zhen)
Establishment date
4 March 2005
Country
China
Primary goods traded
- 💉81.6% — Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products (300241)
- 18.4% — 300220 (300220)
Main Trading Partners
| Partner | Type | Total Value | Percentage |
|---|---|---|---|
| PT Etana Biotechnologies Indonesia | buyer | $15,605,863 | 57.54% |
| PT Mersifarma Tirmaku Mercusana | buyer | $11,515,108 | 42.46% |
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Trade Data
| Data Source | HS Code | Description | Buyer | Buyer Country | Seller | Seller Country | ||
|---|---|---|---|---|---|---|---|---|
| 30 July 2024 | ID | 30024190 | Final Bulk Of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | PT Etana Biotechnologies Indonesia | ID | Yuxi Walvax Biotechnology Company Limited | $1,931,625.50 | |
| 29 December 2023 | ID | 30024190 | Bulk 13-Valent Pneumococcal Polysaccharide Conjugate | PT Etana Biotechnologies Indonesia | ID | Yuxi Walvax Biotechnology Company Limited | $1,597,494.68 | |
| 1 September 2025 | ID | 30024190 | Final Bulk Of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | PT Etana Biotechnologies Indonesia | ID | Yuxi Walvax Biotechnology Company Limited | $1,579,467.78 | |
| 30 September 2025 | ID | 30024190 | Final Bulk Of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | PT Etana Biotechnologies Indonesia | ID | Yuxi Walvax Biotechnology Company Limited | CN | $1,558,306.86 |
| 1 August 2025 | ID | 30024190 | Final Bulk Of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | PT Etana Biotechnologies Indonesia | ID | Yuxi Walvax Biotechnology Company Limited | $1,557,827.04 | |
| 2 June 2025 | ID | 30024190 | Final Bulk Of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | PT Etana Biotechnologies Indonesia | ID | Yuxi Walvax Biotechnology Company Limited | $1,516,334.16 | |
| 16 April 2025 | ID | 30024190 | Final Bulk Of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | PT Etana Biotechnologies Indonesia | ID | Yuxi Walvax Biotechnology Company Limited | $1,313,763.00 | |
| 1 October 2025 | ID | 30024190 | Final Bulk Of 13-Valentpneumococcal Polysaccharideconjugate Vaccine | PT Etana Biotechnologies Indonesia | ID | Yuxi Walvax Biotechnology Company Limited | CN | $1,179,452.34 |
| 21 October 2025 | ID | 30024190 | Final Bulk Of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | PT Etana Biotechnologies Indonesia | ID | Yuxi Walvax Biotechnology Company Limited | CN | $1,089,388.08 |
| 27 October 2025 | ID | 30024190 | Final Bulk Of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | PT Etana Biotechnologies Indonesia | ID | Yuxi Walvax Biotechnology Company Limited | CN | $669,772.62 |
0 of 20 row(s) selected.